key: cord-0067164-e04ifzsc
authors: Otero, Jesse E.
title: Response to “Letter to the Editor”: “Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous?”
date: 2021-09-02
journal: Arthroplast Today
DOI: 10.1016/j.artd.2021.07.014
sha: 50685ec04191beeb637f51da318ac5fa9146493c
doc_id: 67164
cord_uid: e04ifzsc

nan

Letter to the editor Response to "Letter to the Editor": "Failure to Medically Optimize Before Total Hip Arthroplasty: Which Modifiable Risk Factor Is the Most Dangerous?"

The wide availability of the severe acute respiratory syndrome coronavirus 2 (SARS Co-V2) vaccines, along with the concomitant decline in nationwide hospitalizations for coronavirus disease 2019 (COVID-19)-related illness, ushered in a near-return-tonormal pace of practice for many arthroplasty surgeons in the United States. Hospital system screening procedures have persisted which create a safer environment within which to deliver elective surgical services. In July 2020, the International Consensus Group along with the American Association for Hip and Knee Surgeons Research Committee created guidelines for resuming elective total joint arthroplasty [1] . Universal COVID screening for surgical patients, hospital quarantine and shelter-in-place practices, and a push to perform more outpatient and short-stay total hip and total knee arthroplasties in the hospital setting have aimed to reduce the odds of a patient contracting the virus during their surgical episode. One question remains: In the post-2020 era, with many safeguards in place for elective arthroplasty patients, what is the likelihood that a medically optimized elective arthroplasty patient suffers significant COVID-19-related illness as a result of having been exposed in the hospital for their joint replacement? The answer to this question is unknown on a nationwide or even a regional or local scale. Time and observation will be required to gain a clear picture. An argument for or against a vaccine requirement may be made with reliable data. However, another question will then arise: Should patients experiencing pain and disability from osteoarthritis [2] be denied joint replacement if they choose not to become vaccinated? This ethical question will be one for debate.

Resuming elective orthopaedic surgery during the COVID-19 pandemic: guidelines developed by the international Consensus Group (ICM)

Pain and anxiety due to the COVID-19 pandemic: a survey of patients with delayed elective hip and knee arthroplasty